[{"Assets_0_Q3_USD":560875000.0,"CommonStockSharesOutstanding_0_Q3_shares":131001293.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-136974000.0,"NetIncomeLoss_1_Q3_USD":-64415000.0,"NetIncomeLoss_3_Q3_USD":-229248000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":130800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":125240000.0,"StockholdersEquity_0_Q3_USD":45895000.0,"EarningsPerShareBasic_1_Q3_USD":-0.49,"EarningsPerShareBasic_3_Q3_USD":-1.83,"Ticker":"SRNE","CIK":"850261","name":"SORRENTO THERAPEUTICS, INC.","OfficialName":"Sorrento Therapeutics Inc.  Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"636044097.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20191112"}]